DNA synthesis sales will expand through 2036, with oligonucleotide services holding a 47.2% share in 2026 as the leading service type segment. The market was valued at USD 3.70 billion in 2025 and is expected to reach USD 15.64 billion by 2036, creating an incremental opportunity of USD 11.42 billion.